Mean cost of bringing new drug to US market Is $879.3 million
Jul 02, 2024
R&D has remained relatively stable among large pharma companies despite a 27.3% growth in sales.
Adjunctive IV argatroban, eptifibatide do not cut disability after stroke
By
Haymarket Media
Sep 06, 2024
The findings were seen among patients with acute ischemic stroke who were treated with intravenous thrombolysis within three hours after symptom onset.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Increasing thiazide dose linked to greater reduction in calcium
By
Haymarket Media
Aug 28, 2024
The cumulative incidence of symptomatic stone event decreased with the increasing calcium change after thiazide prescription.
New deals will cut Medicare costs for expensive drugs
Aug 15, 2024
The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.
Methotrexate beneficial for reducing pain, stiffness in knee osteoarthritis
Jul 31, 2024
Significant pain reduction was seen in favor of methotrexate; stiffness and function improved at six months.
Nasal sprays, behavioral intervention aid in treatment of respiratory illness
Jul 30, 2024
The use of a gel-based spray or saline spray reduced the duration of illness, whereas all interventions cut antibiotic use.
Extended-release oral ketamine effective for treatment-resistant depression
Jul 17, 2024
Excellent tolerability was seen, with no changes in blood pressure, minimal reports of sedation and minimal dissociation.
1999 to mid-2000s saw increase in seniors using prescription meds
Jul 09, 2024
Polypharmacy increased, peaking at 43.0% in 2017 to March 2020; hyperpolypharmacy increased during 1999-2000 to 2007-2008.
Fewer adults eligible for statins with PREVENT equations
Jun 21, 2024
Compared with the pooled cohort equations, the mean estimated 10-year ASCVD risk was lower using the PREVENT equations across all age, sex and racial subgroups, with the largest difference seen for Black...